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MODULATION OF PHENOTYPIC AND FUNCTIONAL PROPERTIES OF HUMAN
PERIPHERAL BLOOD MONOCYTES BY IL-41
ANJE A. TE VELDE,*2 JAN P. G. KLOMP,* BENITO A. YARD,* JAN E. d e  V R IE S / AND CARL G. FIGDOR*
F rom  the  *Ditnsion o f Im m unology , T h e  N e ther lands  Cancer Institute, A n to n i va n  L e e u w e n h o e k  H u is ,  A m s te r d a m ,  T h e
N e th er la n d s , a n d  'Unicet, Dardilly, France
Highly purified peripheral blood monocytes were 
cultured in the presence of rIL-4. Major changes in 
the morphology of the monocytes were observed. After 
day 5 of culturing the cells acquired a macrophage­
like appearance, with increased cell size and extensive 
processes, suggesting that IL-4 may induce monocyte- 
macro phage differentiation. This notion is supported 
by the observed increased expression of MHC class II 
Ag, which is thought to be associated with monocyte 
differentiation. Exposure of monocytes to IL-4 re­
sulted in a dose-dependent increase of the expression 
of MHC class II Ag, which became apparent after only 
20 h of incubation. Maximal expression was obtained 
after incubation for 6 days, and persisted throughout 
the whole culture period. Similarly, IL-4 increased the 
expression of R for C3bi and pL50.95 Ag, two mem­
bers of the leukocyte function-associated Ag 1 family, 
whereas the expression of the third member, leuko­
cyte function-associated Ag 1, remained unchanged 
during culture. Furthermore, it was shown that IL-4 
inhibited the secretion of cytostatic and chemotactic 
compounds. Supematants of monocytes cultured with 
IL-4 were, in contrast to control cultures, much less 
effective in inhibiting the growth of A375 melanoma 
cells. In addition, these supematants failed to direct 
the migration of freshly isolated monocytes in a chem- 
otaxis assay. Further analysis revealed that these su­
pematants exhibited reduced IL-1 activity, as meas­
ured in a mouse thymocyte proliferation assay, which 
might explain the low cytostatic and chemotactic ac­
tivity.
Taken together these results show that IL-4 modu­
lates monocyte phenotype and function and may in­
duce monocyte-macrophage differentiation in vitro.
Since IL-4 was first described as BSF-1,3 this IL has been 
shown to have important pleiotropic biologic effects in the 
mouse as well as in the human system. Murine BSF-1 (IL-
4) activates preactivated B cells to proliferate (1), and pre­
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pares resting B cells to enter the S phase in response to 
appropriate stimuli (2, 3). In addition, mouse IL-4 has been 
shown to induce/enhance the expression of class II MHC 
Ag on B lymphocytes (4, 5) and to stimulate the growth of 
mast cells (6) and activated T cells (6—8).
By using RNA from Con A-activated human T cells, a 
cDNA coding for the human homologue of mouse IL-4 was 
isolated. The human rIL-4, synthesized with this cDNA in 
cos 7 cells (9), stimulated the growth of preactivated B and 
T cells (9, 10) and induces MHC class II Ag expression on 
normal resting B cells (T. Defrance, unpublished data) and 
malignant B cells4 comparable with mouse IL-4.
It is well established that quantitative variation in class
II MHC Ag plays a major role in the regulation of Ir (1 1 , 
12). Therefore, IL-4 may enhance the Ir by its positive reg­
ulation of class II MHC Ag on B cells. Not only B cells but 
also monocytes and macrophages show a variation of MHC 
class II expression, which is closely related to their function 
in the Ir, and can be modulated by T cell-derived lympho- 
kines (13).
In the present study we investigated the effect of human 
rIL-4 on the modulation of MHC class II Ag expression on 
human peripheral blood monocytes. The monocytes were 
isolated in a way that prevented activation of the cells, so 
that the cells expressed relatively low levels of class II MHC 
Ag. Here it is shown that IL-4 enhances the expression of 
class II MHC Ag on human monocytes, Furthermore, it is 
reported that IL-4 induces a selective up-regulation of the 
expression of CR3 and p i50.95 adhesion associated Ag, a 
macrophage-like morphology and a reduction of the ca­
pacity to secrete IL-1 like activity. The possibility is dis­
cussed that IL-4 may induce monocyte-macrophage differ­
entiation in vitro,
MATERIALS AND METHODS
Isolation of monocytes. Human peripheral blood monocytes were 
isolated from 500 ml of blood from normal h u m an  donors as described 
previously (14, 15). First, mononuclear cells were separated  by density 
centrifugation with a blood component separator. Subsequently the 
mononuclear cells were fractionated into lymphocytes and monocytes 
by centrifugal elutriation. The monocyte preparation  was over 95% 
pure as judged by nonspecific esterase sta in ing  and  contained more 
than  98% viable cells. Contamination with lymphocytes and  granulo­
cytes was generally less than  2 and 3%, respectively.
Monocyte cultures. Monocytes were cultured in a  modified Iscove’s 
medium described by Yssel et al. (16), in which BSA is replaced by 
hum an  serum albumin supplemented with 2% autologous heat-inac­
tivated serum. The culture medium was found to be endotoxin-free 
(defined as less than  0.2 ng/ml of endotoxin as quantified by the Lim- 
ulus amebocyte lysate assay). Monocytes (4 x 10G/ml) were incubated
4 Rousset, F., R. de Waal Malefijt, B. Slierendregt, J. Y. Bonnefoy, T. 
Defrance, J. Banchereau, and J. E. de Vries. 1988. Regulation of Fc re­
ceptor for IgE (CD23) and class II MHC antigen expression on Burkitt lym­
phoma cell lines by human interleukin 4 and interferon-y. J. I m m u n o l .  In- 
press.
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at 37°C, 5% C 0 2 and  100% hum id ity  in  Teflon bags ( J a n s e n ’s MNL, 
St. Niklaas, Belgium). Monocytes cultured for 1 to 14 days were col­
lected from the Teflon bags. After removal of the cu ltu re  su p e rn a ta n t  
the cells were w ashed and  resuspended in PBS con ta in in g  0.5% BSA 
and 0.02% azide and  kept on ice un til the detection of surface m em ­
brane determ inants. The viability by trypan blue exclusion exceeded 
90%. There was no difference in  the num ber of cells th a t  were recovered 
after culture with IL-4 compared with control cu ltu res  (over 80%).
rJL-4. rIL-4 was kindly provided by Dr. K. Aral (DNAX Research In­
stitute, Palo Alto, CA). S u p ern a tan t from cos 7 cells transfected  w ith  
a pcD vector contain ing the h u m an  IL-4 cDNA clone w as used  as source  
of IL-4. As a control m edium , su p ern a tan t from m ock-transfected  cos 
7 cells, processed in the  sam e way, was used (m ock-m edium ). In some 
experiments purified IL-4 (a gift from Dr. S. N agabhushan , S chering  
Corp., Bloomfield, NJ) was used. Purified IL-4 o r  cu ltu re  s u p e rn a ta n t  
containing IL-4 used in the various assays yielded s im ila r  results.
Detection o f surface m em brane  d e te rm in a n ts . C lass II MHC a n d  
LFA-1 family Ag expression w as m easured on freshly isolated and  cul­
tured monocytes. The following anti-class II MHC an tibod ies were used. 
Q5/13 (IgG2a) which detects a determ inant com m on to HLA-DR an d  
HLA-DP molecules (17) was a gift from Dr. S. Ferrone, Medical College, 
Valhalla, NY, and SPV-L3 (IgGl), which reacts w ith a m onom orph ic  
determ inant on HLA-DQ molecules (18). The anti-LFA-1 family a n t i ­
bodies used were: SPV-L7 (IgGl) which recognizes the «-chain  of LFA- 
1 (19), Bear-1 (IgGl) which is sim ilar to anti-CR3 (20) and  detects  the 
a-chain of CR3, S HC1-3 (lgG2b), kindly provided by R. Schw arting , 
Freie Universität Berlin, Berlin, West Germany (21), identifies the et­
ch ain of the p 150.95 Ag, and  CLB 54 (IgGl) (CLB-LFA-1/1) w hich  is 
directed against the common /3-chain of LFA-1, CR3, a n d  p 150.95 (22). 
Another mAb used was sam-1 obtained by im m u n iza tio n  of BALB/c 
mice with hu m an  monocytes isolated by centrifugal é lu tria tion . Sam - 
1 (IgG2b) reacts specifically w ith a 135-kDa Ag on h u m a n  m onocytes 
(data not shown). Control antibodies of various isotypes which did no t 
react with monocytes were directed against idiotypic d e te rm in an ts  on 
B cell lymphoma. Immunofluorescence tests were carried ou t by in ­
cubating the monocytes w ith mAb (in PBS con ta in ing  0.5% BSA an d
0.02% azide) for 30 m in a t 0°C. After three w ash in g s  the m onocytes 
were incubated w ith FITC-labeled goat F(ab)2 an ti-m ouse  IgG an tibody  
(Nordic, Tilburg, The Netherlands) for 30 min a t  0°C. T he  fluorescence 
intensity and the forward light scatter signal (cell size) were m easu red  
by FACS IV analysis. The fluorescence data are expressed in rFI w hich  
were enum erated according to the formula:
rFI cells labeled w ith  
a reactive antibody
rFI cells labeled with control an tibody
Protein syn thesis .  To determ ine protein syn thesis  the  m onocytes 
were metabolically labeled w ith  0.03 mCi/ml [35S]m eth ion ine  (sp. act. 
1000 Ci/mmol, Am ersham  Int., Amersham, England) for 1 h afte r in ­
cubation in methionine-free RPMI medium supp lem en ted  w ith 2% h u ­
m an serum  for 30 min. After the labeling the cells were w ashed  an d  
lysed by a d d in g  1% T r i to n  X -100. T he  a m o u n t  o f in c o r p o r a te d  
[35S]methionine was assessed by liquid scintillation counting .
Migration a n d  chemotaxis.  Random and directed monocyte m ig ra ­
tion was m easured in  a 48-well microchemotaxis ch am ber (23) (Neu­
roprobe, Bethesda, MD). The cham ber consists of an  u p p e r  an d  a  lower 
com partm ent divided into two parts by a lO-fim th ick  polyvinylpyrrol­
idone-free polycarbonate m em brane filter (Nucleopore, P leasanton, CA) 
with 5-fim pores. The lower com partm ent was filled w ith  25 /a1 of m o n o ­
cyte culture m edium  with or w ithout a chem otactic agent. fMLP (10“ 8 
M; Sigma, St. Louis, MO) was used as s tandard  ch em o a ttrac tan t. T he 
chambers were incubated  for 120 m in  at 37°C an d  5% CO-2. After in ­
cubation the nonm igrated cells were removed from the  upper p a r t  of 
the filter. After fixing and  sta in ing  (Diff Quick, Merz an d  Dade AG. 
Dudingen, Switzerland) the m igrated cells which adh ered  to th e  lower 
part of the filter were counted under a microscope. At least 10 random ly 
chosen high power fields (magnification x 400) were counted . S u b ­
sequently the percentage of m igrating cells was calculated.
Growth inhibition o f A375 cells. A375 m elanom a cells were cu ltu red  
in control m edium  (with or w ithout addition ofIL-4) o r in  the presence 
of various concentrations of su p ern a tan t derived from m onocytes cul­
tured with and w ithout IL-4 for 20 h. Growth in h ib it io n  of A375 m el­
anoma cells was determ ined in a clonogenic assay  in  w hich 200 A375 
cells were seeded per well of a 96-well plate (Costar) in  1.2% metliyl- 
cellulose (Methocel MC, 4000 cP, Fluka AG, Sw itzerland) in  Iscove’s 
medium supplem ented w ith 10% heat-inactivated FCS in  a  volum e of 
100 /il. After culture for 1 wk a t 37°C and 5% COa, th e  n u m b e r  of 
colonies of A375 consisting of more than  10 cells w as counted  (colony 
formation), In addition growth inhibitory effects were also m easu red  
on A375 melanoma cells growing in liquid cu ltu res . A375 cells were 
seeded (1000/well of a 96-well plate) (Costar) in  Iscove’s  m edium  s u p ­
plemented with 10% heat-inactivated FCS in a  volum e of 100 /¿l. After
48 h  of in c u b a tio n  a t 37°C an d  5% C 0 2 th e  cells were pu lsed  for 4 h 
w ith 0 .4  /xCi/mmol, New E n g lan d  Nuclear, B oston, MA) after w hich  the 
cells were h a rv es ted  an d  co u n te d  as described  (24). T he  d a ta  are  ex­
pressed  as m ean  cprn [3H]TdR inco rp o ra tio n  of trip licate cu ltu res . The 
A375 ceil line w as free of M y c o p la sm a  co n tam in a tio n .
IL-1 s y n th e s is .  IL-1 activity in  th e  s u p e m a ta n t s  of m onocytes cul­
tu re d  for 20 h  w a s  m easu red  by p ro life ra tion  of m u rin e  thymocytes 
after s t im u la tio n  w ith  Con A, as described  previously (25).
R E S U L T S
Effect of IL-4 on MHC class II Ag expression by human 
monocytes. Monocytes cultured in the presence of IL-4 show 
an increase in the expression of HLA-DR and HLA-DQ Ag 
as compared with control cultures. Culturing of monocytes 
in medium results in an enhanced MHC class II Ag expres­
sion, but in spite of this IL-4 causes a further increase. 
Maximal increase in expression was found at concentra­
tions of 50 U of purified IL-4 (Table I). This concentration 
was used for further phenotypic and functional character­
izations. As a control no increase in expression of a 135- 
kDa monocyte-specific Ag was observed after culturing with 
IL-4 compared with control cultures. The enhanced expres­
sion of class II MHC Ag was already observed after 1 day of 
culturing with and without IL-4, and maximal induction 
was found at day 6 (Table II). Compared with control cul­
tures a 2- to 6-fold increase in HLA-DR expression was 
present on monocytes cultured with IL-4, which persisted 
for at least 14 days. Similar results were found with regard 
to the expression of HLA-DQ (Table II).
Effect of IL-4 on the expression of LFA-1 fam ily  Ag by 
human  monocytes. All three Ag of the LFA-1 family {LFA-
TABLEI
Effect o f IL-4 on the expression o f MHC class II Ag expression by h u m a n
monocytes
ÍL-4 Added 
(ü/ml)
Expression ofa
HLA-DR HLA-DQ 135-kDa monocyte Ag
0 5.7h 2.3 3.7
10 11.3 4.5 3.7
25 15.8 4.6 3.9
50 19.0 6.7 3.6
100 19.0 6.7 3.4
“ Monocytes were labeled with Q5/13 (anti-HLA-DR), SPV-L3 (anti-HLA- 
DQ), or sam-1 (135-kDa monocyte Ag), and GAM F(ab)2 FITC after culture 
with different doses of purified rlL-4 for 20 h.
b Data are expressed as fluorescence index calculated by the formula: 
fluorescence index —
rFI test sample -  rFI negative control (isotype matched)
rFI negative control (isotype matched)
For each value more than 10,000 cells were counted, A representative ex­
periment out of three is shown.
TABLE II
Time course o f effect of IL-4 on MHC class II Ag expression by h u m a n
monocytes
Days
Expression oP
HLA-DR HLA-DQ
+ — + —
0 2.3* 2.3 0.8 0.8
1 10.3 5 .2 2.6 1.3
3 16.0 7.5 3.5 0.8
6 36.5 11.9 NTL' NT
8 18,4 4.0 2.0 0.8
14 9.0 1.5 NT NT
n Monocytes were labeled with Q5/13 (anti-HLA-DR) or SPV-L3 (anti-HLA- 
DQ) and GAM F(ab)2 FITC directly after separation or after culture with (+) 
or w ithout ( - )  50 U of IL-4/ml.
b Data are expressed as fluorescence index calculated by the formula de­
scribed in the footnotes of Table I. For each value more than 10,000 cells 
were counted. A representative experiment out of three is shown. 
c Not tested.
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1 , CR3, and p i50.95) are expressed on human monocytes 
(26). Because these Ag function in monocyte-adhesion re­
actions, which are important in host defenses (26), we in­
vestigated the effect of IL-4 on the expression of LFA-1 fam­
ily Ag on human monocytes. As is shown in Table III 
incubation of monocytes with IL-4 for 3 days modulates 
the expression of CR3, the p i50,95 Ag and the common 
LFA-1 family j3-chain, whereas the expression of LFA-1 a 
was not affected. Again, no change in the level of expression 
of a 135-kDa monocyte-specific Ag was observed upon cul­
ture with IL-4 (Table III). The up-regulation of CR3 and 
p 150.95 becomes apparent within 20 h of incubation and 
the Ag remain elevated throughout the whole culture period 
(7 days, results not shown).
Effect of IL-4 on the moi'phology and metabolic activity 
of cultured human monocytes. The morphology of mono­
cytes cultured with IL-4 does not differ from those cultured 
in the absence of IL-4 during the first 5 days of culturing. 
After this period the monocytes cultured in the presence 
of IL-4 show a strikingly different morphology compared 
with control cultures. At day 6 the cells acquire a macro­
phage-like, dendritic cell morphology and are considerably 
increased in size compared with control cultures. In ad­
dition they have extensive processes (Fig. 1). These results 
were confirmed by the increased forward light scatter signal 
(which is a measure for cell size) obtained with flow cyto­
metry of monocytes cultured in the presence of IL-4 com­
pared with control cultures (Table IV). The increase in cell 
size was accompanied by an increase in protein synthesis 
measured by [35S]methionine incorporation into cultured 
monocytes (Table IV). Furthermore, the phagocytic activity 
of latex beads of monocytes after culture either with or 
without IL-4 was not impaired (data not shown). These data 
suggest that IL-4 induces maturation or differentiation of 
human monocytes.
Effect of IL-4 on human monocyte migration and chem- 
otaxis. Monocytes cultured for 20 h in the presence or ab­
sence of IL-4 were tested on their capacity to produce chem­
otactic cytokines. After this culture period the chemotactic 
activity of the supernatant was tested on freshly isolated 
monocytes and compared with the chemotactic activity of 
control medium with and without IL-4. Figure 2 shows that 
monocytes cultured in medium or mock-medium produce 
a factor that is chemotactic for freshly isolated monocytes 
in a concentration-dependent fashion. Maximal chemotac­
tic activity was obtained at an 1/10 dilution of the monocyte 
supernatant. The percentage of chemotaxis was compa-
TABLE III
Effect o f IL-4 on the expression o f LFA-1 J a m ily  Ag on hum an
monocytesa
Antibody Ag Recognized
Cui Lured for 3 Days 
+ IL-4 -  IL-4
IgGl control IgG (ID) 1 (0) 1 (0)
IgG2b con­ IgG (ID) 1 (0) 1 (0)
trol
SPV-L7 LFA-1 (or-chain) 7 (88) 7 (89)
Bear 1 CR3 (a-chain) 10 (92) 5 (88)
S HC1-3 p l50 .95  (a-chain) 23 (87) 9 (86)
CLB 54 LFA-1, CR3, p l50 .95 11 (92) 4 (94)
(common /3-chain)
Sam 1 135-kDa monocyte 5 (89) 5 (87)
Ag
n Monocytes were labeled with mAb and GAM F (ab)2 FITC after 3 days of 
culture with or without 50 U of IL-4/mI. Data are expressed as rFI and 
percentage positive cells (in parentheses). For each value more than 10,000 
cells were counted. A representative experiment out of three is shown.
rable to the chemotactic responses obtained if fMLP or rlL- 
1 were used as chemoattractant (28 ± 3 and 21 ± 4, re­
spectively). Addition of IL-4 during the chemotaxis assay 
did not affect the migratory response. However, superna- 
tants of monocytes cultured in the presence of IL-4 did not 
contain chemotactic activity. In addition, we investigated 
the chemotactic response of monocytes which were cul­
tured for 20 h. Although supematants of monocytes cul­
tured in the presence of IL-4 did not contain chemotactic 
activity, the monocytes themselves were not affected in their 
capacity to respond to fMLP (Fig. 3). Together, these results 
indicate that IL-4 inhibits the secretion of chemotactic fac­
tors by human monocytes, whereas it does not affect the 
ability of these cells to respond to IMLP.
Effect of IL-4 on the secretion of cytostatic factors by 
human monocytes. Supematants of activated human pe­
ripheral blood monocytes have been shown to contain cy­
tokines with growth inhibitory activity for the human mel­
anoma ceil line A375 (27—30). This cell line was used to 
study the effects of IL-4 on the production of cytostatic 
factors by cultured monocytes. Supematants of monocytes 
cultured for 20 h in the presence or absence of IL-4 were 
added to A375 melanoma cells. As shown in Figure 4 the 
supematants of monocytes cultured in the absence of IL- 
4 strongly reduced the number of A375 colonies, whereas 
supematants of monocytes cultured with IL-4 apparently 
contained less cytostatic factors. The reduction of the growth 
inhibitory activity is already evident at 48 h of culture (Fig. 
5). Addition of IL-4 directly to the A375 cultures did not 
affect colony formation. From these data it can be con­
cluded that monocytes cultured in the presence of IL-4 have 
a reduced capacity to secrete cytostatic factors.
Effect of IL-4 on the synthesis of IL-1 by human mon­
ocytes. It has been shown that human monocytes secrete 
IL-1 upon culture (31). In addition IL-1 can act as a chem­
otactic factor for human monocytes (32) and has cytostatic/ 
cytotoxic effects on certain human tumor cell lines (27). In 
order to investigate whether the reduced chemotactic and 
cytostatic activities described above are attributed to a re­
duction in their capacity to produce IL-1 activity, super- 
natants of monocytes cultured with and without IL-4 were 
tested for IL-1 activity. IL-1 activity was measured by [3H1- 
thymidine incorporation in murine thymocytes stimulated 
with Con A. Supematants of monocytes cultured in the 
presence of IL-4 show a strong reduction of the proliferation 
of thymocytes (Fig. 6) which might explain the reduced 
chemotactic and cytostatic activity found in supematants 
from monocytes cultured in the presence of IL-4, The re­
duced IL-1 activity could not be attributed to IL-4 still pre­
sent in the supernatant, because the thymocyte prolifera­
tion in control medium containing IL-4 was not inhibited 
compared with medium without IL-4.
d is c u s s io n
The recent availability of human rIL-4 gave us the op­
portunity to assess the action of this cytokine on human 
monocytes. By advanced blood component separation in 
combination with centrifugal élutriation it was possible to 
isolate large amounts of highly purified monocytes that are 
equal in size and free of attached thrombocytes (14, 15]. 
Furthermore it has been shown that monocytes isolated 
according to this procedure, are not activated by the iso-
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Figure I . Effect of IL-4 on the morphology of hum an monocytes. Monocytes were cultured for 7 days with mock-medium (a) or with 50 U IL-4/ml (b). 
Morphologic changes became apparent on day 5. No significant shape changes were observed during  further incubation (14 days) (magnification x 200).
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TABLE IV
Effect o f  IL-4 on hum an  monocyte cell s ize  and protein synthesis
IL-4a
Added Expt. 1 Exp I. 2
Cell sizeL — ch. 83 ch. 85
+ c h . 112 ch. 117
Protein syntheslsc — 500 ± 42 750 ± 53
[35S]methionine incorpora­ + 800 ± 64 1125 ± 62
tion [cpm X 10 ”3)
a Monocytes were cultured with or without 50 U IL-4/ml for 6 days. 
b Cell size is expressed as mean channel (ch.) number of the forward light 
scatter signal measured by flow cytometry.
c l35S!Methtonine incorporation was determined as indicated in Materials 
and  Methods. Data are presented as mean ± SD of sixfold values.
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Figure 2. Effect of IL-4 on the production of chemotactic factors by h u ­
man monocytes. Directed migration response of freshly isolated monocytes 
to diluted supernatan t of monocytes (mo-sup) cultured for 20 h with me­
dium ( A .......... A), mock-medium ( Q ............□ )  or 50 U IL-4/ml (■ -------■).
Data are expressed as migration index:
Migration response to mo-sup 
Migration response to control medium
Data of one representative experiment out of four are shown. The migration 
responses to control medium with or withoutIL-4were 12 ±3% and 11 ±2%, 
respectively. SD of triplicate values did not exceed 5%.
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Figure 3. Migratory response of cultured monocytes incubated for 20 h 
in medium, mock medium, or 50 U IL-4/mL The lower compartment of the 
chemotaxis chamber was filled with medium (gray bars) or medium with 
10"8 M ÎMLP (open bars). Values represent m ean±SD  of one representative 
experiment out of five.
lation procedures.5 Such monocyte preparations therefore 
provide an excellent source to study whether IL-4 affects 
the phenotypic and functional characteristics of human 
monocytes,
5 Fig dor, C. G., A. A. te Velde, S. v. d. Heuvel, J . M. M. Leemans, C M. 
G. Thomas, W. S. Boat, and J . E. deVries. 1987. Differences in functional, 
phenotypical and physical properties of hum an peripheral blood monocytes 
reflect various maturation stages. Subm itted  fo r  publication.
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Figure 4. Effect of IL-4 on the secretion of cytostatic factors by human 
monocytes. Colony formation of A375 cells was determined in the presence 
of supernatant of monocytes (mo-sup) cultured for 20 h in medium 
( A ..........A), mock-medium ( □ ............Q) or 50 U IL-4/ml (■ ------ ■). Data
are expressed as percentage inhibition of colony formation of A375 cells 
according to the formulai
100
num ber of colonies in mo-sup 
num ber of colonies In control medium
x 100%
Data of one representative experiment out of four are shown. The number 
of colonies formed In control medium with or without IL-4 were 91 ± 4  and 
87 ± 5, respectively. SD of the number of colonies of six wells did not exceed 
8%.
Monocytes play a central role in the regulation of Ir and 
modulation of the expression of class II MHC Ag seems to 
be a closely correlated event (13, 33). Upon culture the 
expression of class II MHC Ag on monocytes increases rap­
idly (34) (Table II). In addition culture supernatants of lec­
tin-activated lymphocytes can increase the expression of 
these Ag and IFN-7 has been shown to be the inducing agent 
(35). Here it is demonstrated that IL-4 also increases the 
expression of class II MHC Ag in a dose-dependent manner 
(Tables I and II), The up-regulation of class II MHC Ag on 
monocytes by IL-4 could not be attributed to other com­
pounds in the cos 7 transfection supernatants, since pur­
ified rIL-4 has similar effects. Moreover, HLA-DR expres­
sion was not affected by supernatants of mock-transfected 
cos 7 cells. The observation that IL-4 modulates class II Ag 
expression in human peripheral blood monocytes may in­
dicate that IL-4 has important immunoregulatory activi­
ties. An intriguing question is whether this increased MHC 
class II expression has any functional consequences, such 
as improved Ag-presenting capability of human monocytes. 
Zlotnik et al. (36) have already demonstrated that murine 
rIL-4 induced the Ag-presentihg ability in mouse B cells or 
bone marrow-derived macrophages, and is accompanied 
with a small but significant increase in la Ag expression.
In addition to class II MHC Ag the LFA-1 family of mol­
ecules has been implicated in the function of monocytes. 
These Ag act as adhesion molecules mediating cell-sub- 
strate and cell-cell interactions of myeloid and lymphoid 
cells (26). When monocytes are cultured in the presence of 
IL-4 the expression of the CR3 and p 150.95 Ag is up-reg-
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Figure 5. Effect of IL-4 on the secretion of cytostatic factors by hum an 
monocytes. Proliferation of A375 cells was measurd in the presence of s u ­
pernatant of monocytes (mo-sup) cultured in medium ( A ........... A), mock-
medium ( □ ..........□)♦ or 50 U IL-4/ml (■ -------■). Data are expressed asi p I I  I J < V i  w v  W  * » * * » *  K ^ r n  " r  ^ -  ' ■ ’ " r ------------------------- - '
percentage inhibition of [3Hlthymidine incorporation of A375 cells according 
to the formula;
100 -
[3Hlthymidine incorporation in mo-sup 
(3Hlthymidine incorporation in control medium
x 100%.
Data of two individual experiments are shown. The [3H]thymidine incor­
poration in control medium was 55,000±4,900 and 21,000±1,900, re­
spectively. Similar values were obtained with control medium containing 
IL-4. SD of six samples did not exceed 10%.
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Figure 6. Effect of IL-4 on the production ofIL-1 by hum an monocytes. 
Monocytes were cultured for 20 h with (■----- ■) or without ( A ...........A)
50 U purified IL-4/ml. The IL-1 in the supernatan t was determined 
by (3H1 thymidine incorporation (cpm 10~3) in  murine thymocytes activated 
by Con A. Values represent mean ±SD of one representative experiment out 
of three.
ulated, whereas the expression of the LFA-1 Ag remains 
unchanged (Table III). A similar selective up-regulation of 
CR3 and p 150.95 Ag was found upon activation of mon­
ocytes by inflammatory stimuli (26). The surface expres­
sion of CR3 and p i50.95 Ag is rapidly increased by mo­
bilization of these Ag from intracellular pools to the cell 
surface within 30 min, but LFA-1 Ag expression was not 
increased upon activation (26). In addition, differentiation
unchanged (Table III). A similar selective up-regulation of 
CR3 and p i 50.95 Ag was found upon activation of mon­
ocytes by inflammatory stimuli (26). The surface expres­
sion of CR3 and p i50.95 Ag is rapidly increased by mo­
bilization of these Ag from intracellular pools to the cell 
surface within 30 min, but LFA-1 Ag expression was not 
increased upon activation (26). In addition, differentiation 
of myeloid cells results in a similar but much slower in­
crease in the expression of CR3 and p i 50.95 Ag, whereas 
the LFA-1 Ag expression remains stable (37). These latter 
findings closely resemble the results obtained when mon­
ocytes are cultured in the presence of IL-4 (Table III)*
Upon comparison of the data concerning enhanced 
expression of class IIMHC m o le c L i le s  and LFA-1 family mol­
ecules with the literature (37, 38) it can be concluded that 
the phenotypic changes of monocytes cultured with IL-4 
are similar to the changes observed when monocytes dif­
ferentiate into macrophages, indicating that IL-4 induces 
differentiation of human monocytes. This notion is sup­
ported by the morphology seen after prolonged culture in 
the presence of IL-4 (Fig. 1).
Upon activation, monocytes secrete a large number of 
immunoregulatory factors which mediate multiple activi­
ties on a variety of cells (39), Here we demonstrate that IL- 
4 inhibits the secretion of such factors, especially those 
with autostimulatory chemotactic and cytostatic activity, 
However, since multiple monocyte products with similar 
biologic activity have been described, it is difficult to at­
tribute the inhibitory activity of IL-4 to the reduced secre­
tion of a single component. According to Nathan (39) many 
monocyte products are capable to act as chemoattractant. 
From these products IL-1 (32) and fibronectin fragments 
(40) have been shown to be chemotactic for human mon­
ocytes. Recently also other monocyte derived factors such 
as granulocyte-macrophage colony-stimulating factor (41) 
and TNF (42) were capable of inducing directed migration 
of human monocytes. With respect to the inhibition of cell­
ular proliferation even more monocyte-derived products have 
been reported (39), Thus far, two candidates, IL-1 and TNF, 
inhibited both the growth of A375 cells and possess chem­
otactic activity (27—30, 32). We have started experiments 
to identify the factors secreted in reduced amounts after 
incubation of monocytes with IL-4. Figure 6 shows that IL- 
4 inhibits the production of IL-1-like activity identified by 
the reduced ability to co-stimulate (with Con A) the prolif­
eration of mouse thymocytes (Fig. 6). Since TNF has not 
been reported to stimulate the thymocyte proliferation, these 
data may indicate that IL-4 acts predominantly on the se­
cretion of IL-1, but its effect on the production of other 
monokines cannot be excluded.
Finally, loss of IL-1 activity is associated with the in vitro 
maturation of monocytes to macrophages (43) (see footnote
5). Also tissue macrophages failed to produce IL-1 (44, 45). 
These findings further support the hypothesis that IL-4 
induces in vitro monocyte differentiation into macro­
phages.
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